EKF Diagnostics Holdings Plc (EKF)

London
33.58
+0.53(+1.62%)
  • Volume:
    1,463
  • Bid/Ask:
    32.70/33.60
  • Day's Range:
    33.58 - 33.58

EKF Overview

Prev. Close
33.05
Day's Range
33.58-33.58
Revenue
81.84M
Open
32.6
52 wk Range
30-86.8
EPS
0.03
Volume
1,463
Market Cap
150.35M
Dividend (Yield)
1.10
(3.33%)
Average Volume (3m)
797,026
P/E Ratio
9.60
Beta
0.8
1-Year Change
-58.58%
Shares Outstanding
454,930,564
Next Earnings Date
11 Sept 2022
What is your sentiment on EKF Diagnostics?
or
Vote to see community's results!

EKF Diagnostics Holdings Plc Company Profile

EKF Diagnostics Holdings Plc Company Profile

EKF Diagnostics Holdings plc is primarily engaged in designing, developing, manufacturing and selling diagnostic instruments, reagents and ancillary products, as well as central laboratory reagents. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. It operates in Germany, the United States, Russia and the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Looks good value now after the release of its earnings on 21st March.
    0